On February 23, 2026 Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, reported participation in three upcoming investor conferences.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

46th Annual Cowen Healthcare Conference (Boston, MA)

Monday, March 2, 2026, Eric Crombez, M.D., Chief Medical Officer, will participate in a fireside chat and host 1×1 meetings.

Barclays 28th Annual Global Healthcare Conference (Miami, FL)

Tuesday, March 10, 2026, Eric Crombez will participate in a fireside chat and host 1×1 meetings.

Leerink Partners Global Biopharma Conference (Miami, FL)

Wednesday, March 11, 2026, Eric Crombez will participate in a fireside chat and host 1×1 meetings.

The live and archived webcast of the fireside chat will be accessible from the company’s website at View Source

(Press release, Ultragenyx Pharmaceutical, FEB 23, 2026, View Source [SID1234662868])